Business Description
Beijing Scitop Bio-tech Co Ltd
ISIN : CNE100004181
Share Class Description:
SZSE:300858: Class ACompare
Compare
Traded in other countries / regions
300858.China IPO Date
2020-07-27Description
Beijing Scitop Bio-tech Co Ltd is engaged in production and sales of compound food additives, edible probiotic products and animal and plant micro-ecological preparations. The company engages in provision of biotechnology services, consulting, development, transfer; development and sale of stereotyped packaged food additives, compound food additives. Its products include Probio-M8 and Probio-M9.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 90.22 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 112.49 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 44.08 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -14.3 | |||||
| 3-Year EBITDA Growth Rate | -10.7 | |||||
| 3-Year EPS without NRI Growth Rate | -13.4 | |||||
| 3-Year Book Growth Rate | 16.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.27 | |||||
| 9-Day RSI | 43.16 | |||||
| 14-Day RSI | 42.63 | |||||
| 6-1 Month Momentum % | -16.78 | |||||
| 12-1 Month Momentum % | -4.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 21.47 | |||||
| Quick Ratio | 20.62 | |||||
| Cash Ratio | 10.2 | |||||
| Days Inventory | 129.27 | |||||
| Days Sales Outstanding | 72.14 | |||||
| Days Payable | 56.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.03 | |||||
| Dividend Payout Ratio | 0.89 | |||||
| Forward Dividend Yield % | 1.03 | |||||
| 5-Year Yield-on-Cost % | 1.05 | |||||
| 3-Year Average Share Buyback Ratio | -5.8 | |||||
| Shareholder Yield % | 0.97 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.05 | |||||
| Operating Margin % | 24.14 | |||||
| Net Margin % | 32.14 | |||||
| FCF Margin % | -30.93 | |||||
| ROE % | 5.35 | |||||
| ROA % | 5.15 | |||||
| ROIC % | 4.85 | |||||
| ROC (Joel Greenblatt) % | 11.13 | |||||
| ROCE % | 5.84 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.94 | |||||
| PE Ratio without NRI | 43.32 | |||||
| Price-to-Owner-Earnings | 456.25 | |||||
| PS Ratio | 13.77 | |||||
| PB Ratio | 2.2 | |||||
| Price-to-Tangible-Book | 2.26 | |||||
| Price-to-Operating-Cash-Flow | 34.68 | |||||
| EV-to-EBIT | 33.8 | |||||
| EV-to-EBITDA | 33.8 | |||||
| EV-to-Revenue | 11.97 | |||||
| EV-to-FCF | -38.69 | |||||
| Price-to-Projected-FCF | 2.47 | |||||
| Price-to-Peter-Lynch-Fair-Value | 7.77 | |||||
| Price-to-Graham-Number | 2.09 | |||||
| Price-to-Net-Current-Asset-Value | 4.53 | |||||
| Price-to-Net-Cash | 10.28 | |||||
| Earnings Yield (Greenblatt) % | 2.96 | |||||
| FCF Yield % | -2.3 | |||||
| Forward Rate of Return (Yacktman) % | 6.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Scitop Bio-tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 286.12 | ||
| EPS (TTM) (Â¥) | 0.34 | ||
| Beta | 0.91 | ||
| Volatility % | 26.71 | ||
| 14-Day RSI | 42.63 | ||
| 14-Day ATR (Â¥) | 0.578293 | ||
| 20-Day SMA (Â¥) | 14.9365 | ||
| 12-1 Month Momentum % | -4.03 | ||
| 52-Week Range (Â¥) | 13.81 - 21.41 | ||
| Shares Outstanding (Mil) | 263.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Scitop Bio-tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Scitop Bio-tech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Scitop Bio-tech Co Ltd Frequently Asked Questions
What is Beijing Scitop Bio-tech Co Ltd(SZSE:300858)'s stock price today?
The current price of SZSE:300858 is ¥14.60. The 52 week high of SZSE:300858 is ¥21.41 and 52 week low is ¥13.81.
When is next earnings date of Beijing Scitop Bio-tech Co Ltd(SZSE:300858)?
The next earnings date of Beijing Scitop Bio-tech Co Ltd(SZSE:300858) is .
Does Beijing Scitop Bio-tech Co Ltd(SZSE:300858) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Scitop Bio-tech Co Ltd(SZSE:300858) is 1.03% (As of Today), Highest Dividend Payout Ratio of Beijing Scitop Bio-tech Co Ltd(SZSE:300858) was 1. The lowest was 0.76. And the median was 0.97. The  Forward Dividend Yield % of Beijing Scitop Bio-tech Co Ltd(SZSE:300858) is 1.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers